Wang, Yu-Qian <br/><br/>
Enhancement of survivin-specific anti-tumor immunity by adenovirus prime protein-boost immunity strategy with DDA/MPL adjuvant in a murine melanoma model.  [electronic resource] 

 -  International immunopharmacology  Sep 2013 
 - 9-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2013.04.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic<br/>Animals<br/>Cancer Vaccines<br/>Cell Line<br/>Cell Proliferation<br/>Female<br/>Humans<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Lipid A--administration & dosage<br/>Melanoma--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Neoplasms, Experimental<br/>Organoplatinum Compounds<br/>Oxaliplatin<br/>Quaternary Ammonium Compounds--administration & dosage<br/>Specific Pathogen-Free Organisms<br/>Survivin<br/>T-Lymphocyte Subsets